Cargando...

Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial

BACKGROUND: Psoriasis is an immune-mediated chronic inflammatory skin disorder for which several targeted biologic therapies became available in the last 10 years. Data from patients with rheumatoid arthritis revealed that dose tapering combined with tight control of disease activity is successful....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Dermatol
Main Authors: Atalay, Selma, van den Reek, Juul M. P. A., van Vugt, Lieke J., Otero, Marisol E., van de Kerkhof, Peter C. M., den Broeder, Alfons A., Kievit, Wietske, de Jong, Elke M. G. J.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422943/
https://ncbi.nlm.nih.gov/pubmed/28482858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12895-017-0057-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!